Search results
What to Know About the 'FLiRT' Variants of COVID-19
Time Magazine· 6 days agoThe COVID-19 lull in the U.S. may soon come to an end, as a new family of SARS-CoV-2 variants—nicknamed “FLiRT” variants—begins to spread nationwide....
After COVID vaccine rollout, negativity on Twitter spiked
Center for Infectious Disease Research and Policy· 6 days agoAfter the introduction of COVID-19 vaccines at the end of 2020, there was an average 10,201 more ...
COVID-19 hospitalizations hit record low
Fortune via Yahoo Finance· 3 days agoVaccination numbers still aren’t especially high, though. The latest CDC figures show 22.6% of the nation’s adults are up to date on their COVID-19 < ...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 4 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 5 days agoSyndrome, involving unusual and severe blood clotting events associated with low platelet counts,...
Medical license reinstated for doctor who made false claims against COVID-19 vaccines
WCMH via Yahoo News· 2 days agoView a previous report on the investigation into the doctor’s magnetism claim in the video player...
FLiRT – All You Need To Know About The Latest COVID-19 Variants
IFLScience· 5 days agoThere’s a family of new COVID-19 variants in town, and at least one of them looks set to begin...
WHO COVID vaccine advisers recommend switch to JN.1 strain
Center for Infectious Disease Research and Policy· 6 days agoThe World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition, which...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 3 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called ...
Fauci: US to spend $3.2B for antiviral pills for COVID-19
AOL· 10 hours agoThe United States is devoting $3.2 billion to advance development of antiviral pills for COVID-19 and other dangerous viruses that could turn into pandemics ...